Christian S. Schade
2019
In 2019, Christian S. Schade earned a total compensation of $3.7M as President and Chief Executive Officer at Aprea Therapeutics, a 520% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $210,148 |
|---|---|
| Option Awards | $3,021,059 |
| Salary | $446,360 |
| Total | $3,677,567 |
Schade received $3M in option awards, accounting for 82% of the total pay in 2019.
Schade also received $210.1K in non-equity incentive plan and $446.4K in salary.
Rankings
In 2019, Christian S. Schade's compensation ranked 3,288th out of 13,971 executives tracked by ExecPay. In other words, Schade earned more than 76.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,288 out of 13,971 | 77th |
Division Manufacturing | 1,189 out of 5,701 | 79th |
Major group Chemicals And Allied Products | 406 out of 2,200 | 82nd |
Industry group Drugs | 335 out of 1,886 | 82nd |
Industry Pharmaceutical Preparations | 251 out of 1,398 | 82nd |
Source: SEC filing on April 29, 2020.
Schade's colleagues
We found two more compensation records of executives who worked with Christian S. Schade at Aprea Therapeutics in 2019.
News
Aprea Therapeutics CEO Christian Schade's 2022 pay falls 58% to $1.4M
July 11, 2023
Aprea Therapeutics CEO Christian Schade's 2021 pay slips 17% to $3.2M
June 10, 2022
Aprea Therapeutics CEO Christian Schade's 2020 pay rises 6% to $3.9M
April 28, 2021
Aprea Therapeutics CEO Christian Schade's 2019 pay jumps 520% to $3.7M
April 29, 2020